Susan Henley Manning, Ph.D. has over 30 years of economics and litigation consulting experience, including extensive expertise in antitrust and competition issues, mergers and acquisitions, and regulatory policy analysis. Dr. Manning has provided economic analyses in support of healthcare related mergers and acquisitions, filed under the Hart‐Scott‐Rodino Act, before the Department of Justice and Federal Trade Commission, focusing on competitive effects and efficiencies and consumer welfare benefits of proposed transactions.
Dr. Manning’s most recent healthcare work has focused on using sound empirical economic analysis to identify levers for improving access and quality of healthcare within a community with more cost‐efficient delivery structures, such as integrated care organizations and accountable health communities. These analyses make use of empirical and econometric analyses of market, demographic, and individual firm characteristics of healthcare costs and spending in an effort to isolate key drivers of costs while controlling for the population’s health and other demographic profiles.
Dr. Manning has used microsimulation and other economic models to assess the demand for healthcare services and resources, including advanced methods for treating cancer. She has also focused on assessing and modeling the impact of organizational change, rationalization, and re‐alignment of capacity on the quality of care and effectiveness in meeting a population’s present and future healthcare needs. This multi‐step analysis includes analyzing the current provision of healthcare in community delivered through various healthcare facilities and programs, assessing present and future healthcare needs of the community, and determining the most cost efficient and best quality of care delivery structure for delivering healthcare within a community as predicted population healthcare needs change. Dr. Manning’s work also has incorporated examination of appropriate economic incentives for inducing change.
Dr. Manning has worked extensively in the UK on healthcare issues involving transformational change in the delivery of care. These engagements include an assessment of intermediate care needs for NWL CCG, and development of outcomes‐based modelling and ACO development in West Essex. In addition, Dr. Manning is the project lead and designer of the FTI Consulting Healthcare Transformation Reform Model used in the Respiratory Project for the West Essex ACP which assessed the demand for COPD services and estimated potential cost savings from COPD care interventions. Dr. Manning is working with the West Essex ACP to develop a new outcomes‐based contract for COPD services based on the model’s results.
T: +1 202 589 3458
555 12th Street, NW
Washington, DC, 20004
Antitrust & Competition Economics